Apollomics Inc.
Income Statement
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $-53.6M | $-172.6M | $976.0K | $-94.8M | $-74.9M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Pretax Income | $-53.6M | $-172.6M | $-240.8M | $-94.8M | $-74.9M |
| Income Tax Expense | $259.0K | $10.0K | $1.0K | $1.0K | $-85.0K |
| Net Income | $-53.9M | $-172.6M | $-240.8M | $-94.8M | $-74.8M |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | $-52.80 | $-231.99 | $-844.95 | $-3.37 | $-0.21 |
| EPS (Diluted) | $-52.80 | $-231.99 | $-844.95 | $-3.37 | $-0.21 |
| Shares Outstanding (Basic) | 89.5M | — | — | — | — |
| Shares Outstanding (Diluted) | 89.5M | — | — | — | — |
| Dividends Per Share | — | — | — | — | — |